Truvestments Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-89
| Closed | -$11.7K | – | 1110 |
|
|
2025
Q1 | $11.7K | Hold |
89
| – | – | ﹤0.01% | 629 |
|
|
2024
Q4 | $7.43K | Hold |
89
| – | – | ﹤0.01% | 650 |
|
|
2024
Q3 | $6.51K | Buy |
+89
| New | +$6.69K | ﹤0.01% | 648 |
|
|
2024
Q2 | – | Sell |
-89
| Closed | -$6.16K | – | 719 |
|
|
2024
Q1 | $6.16K | Hold |
89
| – | – | ﹤0.01% | 539 |
|
|
2023
Q4 | $6.37K | Hold |
89
| – | – | ﹤0.01% | 567 |
|
|
2023
Q3 | $4.64K | Hold |
89
| – | – | ﹤0.01% | 517 |
|
|
2023
Q2 | $5.63K | Hold |
89
| – | – | ﹤0.01% | 514 |
|
|
2023
Q1 | $4.82K | Hold |
89
| – | – | ﹤0.01% | 516 |
|
|
2022
Q4 | $4.71K | Sell |
89
-59
| -40% | -$2.96K | ﹤0.01% | 557 |
|
|
2022
Q3 | $7K | Hold |
148
| – | – | ﹤0.01% | 450 |
|
|
2022
Q2 | $8K | Buy |
+148
| New | +$8.39K | ﹤0.01% | 441 |
|
|
2022
Q1 | – | Sell |
-148
| Closed | -$8K | – | 579 |
|
|
2021
Q4 | $8K | Hold |
148
| – | – | ﹤0.01% | 429 |
|
|
2021
Q3 | $6K | Hold |
148
| – | – | ﹤0.01% | 441 |
|
|
2021
Q2 | $6K | Hold |
148
| – | – | ﹤0.01% | 446 |
|
|
2021
Q1 | $5K | Sell |
148
-47
| -24% | -$1.63K | ﹤0.01% | 528 |
|
|
2020
Q4 | $6K | Buy |
+195
| New | +$5.13K | ﹤0.01% | 483 |
|
|
2020
Q3 | – | Sell |
-195
| Closed | -$5K | – | 578 |
|
|
2020
Q2 | $5K | Buy |
+195
| New | +$3.95K | 0.01% | 466 |
|
|
2019
Q4 | – | Sell |
-345
| Closed | -$3K | – | 629 |
|
|
2019
Q3 | $3K | Sell |
345
-35
| -9% | -$336 | ﹤0.01% | 647 |
|
|
2019
Q2 | $5K | Hold |
380
| – | – | ﹤0.01% | 628 |
|
|
2019
Q1 | $5K | Buy |
+380
| New | +$4.86K | ﹤0.01% | 612 |
|
|
2018
Q3 | $9K | Buy |
+395
| New | +$8.26K | ﹤0.01% | 664 |
|
Other funds holding ITCI
KIM
HNB
Truvestments Capital's ITCI Position: Q2 2025 in Review
Truvestments Capital sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 89 shares — an estimated $11.7K sold.
Truvestments Capital first reported a position in ITCI in Q3 2018 and held it in 21 quarters. The position peaked at $11.7K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- Truvestments Capital reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- Truvestments Capital sold 89 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $11.7K.
- Truvestments Capital first reported a position in Intra-Cellular Therapies Inc. in Q3 2018 and held it in 21 quarters.
- Truvestments Capital's Intra-Cellular Therapies Inc. position peaked at $11.7K in Q1 2025.
- 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on Truvestments Capital's 13F filing for Q2 2025, filed 13 Aug 2025.